Spectrum Pharmaceuticals Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Spectrum Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Spectrum Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Spectrum Pharmaceuticals is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Spectrum |
Spectrum Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Spectrum Pharmaceuticals on September 30, 2025 and sell it today you would earn a total of 100.00 from holding Spectrum Pharmaceuticals or generate -100.0% return on investment over 90 days. Spectrum Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Spectrum, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Spectrum Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectrum Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spectrum Pharmaceuticals, and traders can use it to determine the average amount a Spectrum Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SPPI |
Based on monthly moving average Spectrum Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spectrum Pharmaceuticals by adding Spectrum Pharmaceuticals to a well-diversified portfolio.
Spectrum Pharmaceuticals Fundamentals Growth
Spectrum Stock prices reflect investors' perceptions of the future prospects and financial health of Spectrum Pharmaceuticals, and Spectrum Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectrum Stock performance.
| Return On Equity | -1.65 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.52) % | |||
| Operating Margin | (2.47) % | |||
| Current Valuation | 185.27 M | |||
| Shares Outstanding | 205.25 M | |||
| Price To Earning | (19.44) X | |||
| Price To Book | 2.40 X | |||
| Revenue | 10.11 M | |||
| EBITDA | (77.06 M) | |||
| Cash And Equivalents | 67.96 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 29.43 M | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.13 X | |||
| Cash Flow From Operations | (96.99 M) | |||
| Earnings Per Share | (0.36) X | |||
| Total Asset | 103.34 M | |||
| Retained Earnings | (1.12 B) | |||
| Current Asset | 2.57 M | |||
| Current Liabilities | 2.52 M | |||
Things to note about Spectrum Pharmaceuticals performance evaluation
Checking the ongoing alerts about Spectrum Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spectrum Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectrum Pharmaceuticals is not yet fully synchronised with the market data | |
| Spectrum Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Spectrum Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 10.11 M. Net Loss for the year was (75.4 M) with profit before overhead, payroll, taxes, and interest of 8.32 M. | |
| Spectrum Pharmaceuticals currently holds about 67.96 M in cash with (96.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37. |
- Analyzing Spectrum Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectrum Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Spectrum Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectrum Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectrum Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectrum Pharmaceuticals' stock. These opinions can provide insight into Spectrum Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |